King's College Hospital NHS Trust
kch.nhs.ukTotal trials
163
Active
43
Phase 3
11
Total enrollment
174,554
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Carvedilol | — | — | — | — | — | 2 | |
| Colchicine 0.5 MG | — | — | — | — | — | 1 | |
| Intravitreal 2 mg aflibercept will be injected at baseline then monthly for two further doses, then 2-monthly until month 12 | — | — | — | — | — | 1 | |
| subretinal injection of recombinant TPA (Alteplase) up to a maximum of 25 micrograms in 0.2 mls | — | — | — | — | — | 1 | |
| Intravitreal 20% sulfahexafluoride (SF6) gas tamponade | — | — | — | — | — | 1 | |
| HMB002 | — | — | — | — | — | 1 | |
| Angiotensin II | — | — | — | — | — | 1 | |
| Vasopressin | — | — | — | — | — | 1 | |
| Norepinephrine | — | — | — | — | — | 1 | |
| Dapagliflozin | — | — | — | — | — | 1 | |
| Blood and nasal swab sampling | — | — | — | — | — | 1 | |
| Empirical Hydrocortisone Protocol | — | — | — | — | — | 1 | |
| Targeted Treatment Protocol | — | — | — | — | — | 1 |
Next readouts
- 2025-04-08
- 2025-10-05
- 2025-11
- 2026-01
- 2026-12
- 2027-12-31
- 2028-09
- 2028-12
Top conditions
- Chronic Kidney Diseases5
- Obesity5
- Leukemia, Myeloid, Acute5
- Myelodysplastic Syndromes5
- Cardiovascular Diseases4
- Dyspnea4
- Diverticular Disease4
- Miscarriage in First Trimester3
Frequently asked questions about King's College Hospital NHS Trust
- How many clinical trials does King's College Hospital NHS Trust have on ClinicalTrials.gov?
- King's College Hospital NHS Trust is listed as the lead sponsor on 163 clinical trials in ClinicalTrials.gov, 43 of which are currently active (recruiting, enrolling, or ongoing).
- How many of King's College Hospital NHS Trust's trials are in Phase 3?
- 11 of King's College Hospital NHS Trust's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does King's College Hospital NHS Trust focus on?
- King's College Hospital NHS Trust's most-studied conditions on ClinicalTrials.gov are Chronic Kidney Diseases, Obesity, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Cardiovascular Diseases.
- When are King's College Hospital NHS Trust's next clinical trial readouts?
- King's College Hospital NHS Trust has 8 upcoming primary-completion readouts tracked here; the soonest is “Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)”, expected around 2025-04-08.